James A. McNulty, CPA
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James A. McNulty, CPA
James A. McNulty, CPA is recorded as CFO at Inhibitor Therapeutics, Inc. (INTI). Inhibitor Therapeutics, Inc. reported in an 8-K filed December 19, 2022 that James A. McNulty, CPA was appointed Chief Financial Officer, Treasurer and Secretary of the Company, effective December 13, 2022.
“On December 13, 2022, the Board of the Company appointed James A. McNulty, CPA as Chief Financial Officer, Treasurer and Secretary of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-12-13–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Inhibitor Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Francis E. O'Donnell CEO, Board Member
- Francis E. O'Donnell, Jr. CEO, Chairman
- Francis E. O'Donnell, Jr., M.D. CEO, Chairman
- James A. McNulty CFO
- Michael Jerman Board Member
- Michael Jerman, CPA. Board Member
- Michelle Yanez Board Member
- Michelle Yanez, MBA Board Member
- Niraj Vasisht Board Member
- Niraj Vasisht, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.